Skip to main content
. 2014 Sep 2;5:159. doi: 10.3389/fneur.2014.00159

Table 2.

Microdialysis parameters.

Patient Brain-MD
CSF-MD
Glucose (mmol/L) Lactate (mmol/L) Pyruvate (μmol/L) LPR Glycerol (μmol/L) Glucose (mmol/L) Lactate (mmol/L) Pyruvate (μmol/L) LPR Glycerol (μmol/L)
1 1.9 (0.9–3.2) n = 45 5.9 (3.1–8.5) n = 45 141 (93–224) n = 44 49 (34–54) n = 45 106 (89–125) n = 45 4.7 (2.4–5.0) n = 31 2.0 (1.9–2.2) n = 32 73 (62–83) n = 30 27 (24–33) n = 31 57 (27–62) n = 31
2 1.4 (0.6–1.8) n = 157 4.9 (4.1–6.2) n = 154 148 (135–168) n = 156 33 (30–35) n = 154 181 (143–310) n = 157 5.0 (4.8–5.4) n = 113 2.9 (2.5–3.4) n = 112 85 (75–100) n = 105 34 (28–42) n = 105 73 (44–103) n = 114
3 0.6 (0.5–0.8) n = 163 3.5 (2.8–4.2) n = 160 100 (72–144) n = 149 35 (29–43) n = 148 361 (242–874) n = 158 4.9 (4.3–5.5) n = 110 2.4 (2.2–2.7) n = 108 113 (105–123) n = 94 22 (19–25) n = 93 32 (22–40) n = 111
4 1.6 (1.1–2.1) n = 241 2.6 (2.3–3.1) n = 263 112 (88–126) n = 265 24 (22–29) n = 262 987 (706–1420) n = 259 5.5 (4.4–6.9) n = 125 1.8 (1.6–2.1) n = 124 82 (67–99) n = 124 22 (20–25) n = 124 38 (32–51) n = 125
5 4.0 (3.2–4.5) n = 129 2.5 (2.0–3.2) n = 124 130 (112–147) n = 122 19 (16–25) n = 118 483 (243–877) n = 127 4.8 (4.5–5.1) n = 125 2.3 (1.9–2.5) n = 123 94 (80–111) n = 122 23 (18–29) n = 116 99 (86–112) n = 125
6 5.9 (5.5–6.3) n = 55 2.1 (1.9–2.4) n = 58 130 (122–149) n = 50 15 (15–18) n = 46 87 (77–107) n = 58 4.8 (4.6–5.1) n = 97 1.7 (1.6–1.9) n = 96 63 (60–69) n = 96 27 (24–29) n = 92 29 (25–34) n = 96
7 1.6 (1.1–2.2) n = 112 7.4 (6.2–8.6) n = 119 269 (255–284) n = 118 27 (23–32) n = 125 120 (66–238) n = 118 5.1 (4.6–5.5) n = 110 3.2 (2.9–3.4) n = 116 124 (108–158) n = 114 25 (20–31) n = 119 44 (39–57) n = 115
8 0.5 (0.3–1.1) n = 75 7.2 (4.9–7.8) n = 67 157 (128–185) n = 68 45 (40–49) n = 64 184 (91–359) n = 70 4.3 (3.9–4.8) n = 147 2.7 (2.5–2.9) n = 149 112 (101–124) n = 146 24 (23–27) n = 146 64 (55–76) n = 148
9 1.2 (0.8–1.5) n = 213 5.0 (3.6–6.3) n = 230 137 (92–173) n = 216 35 (31–40) n = 215 87 (58–115) n = 215 5.2 (4.6–6.0) n = 150 3.6 (3.2–4.1) n = 151 151 (138–172) n = 148 24 (22–26) n = 145 58 (38–72) n = 149
10 1.0 (0.8–1.3) n = 89 2.6 (2.2–3.0) n = 93 102 (94–117) n = 89 24 (22–26) n = 89 2273 (1817–2529) n = 94 5.6 (4.7–7.0) n = 123 4.7 (4.1–5.1) n = 128 199 (179–228) n = 125 23 (20–26) n = 125 82 (66–113) n = 127
11 0.9 (0.8–1.2) n = 151 3.4 (2.9–3.9) n = 152 112 (92–125) n = 148 32 (29–34) n = 145 451 (269–1133) n = 153 5.4 (4.9–5.9) n = 150 2.8 (2.6–3.1) n = 145 100 (94–114) n = 142 28 (25–30) n = 139 66 (58–75) n = 147
12 1.0 (0.7–1.2) n = 100 5.2 (4.5–5.8) n = 99 166 (154–183) n = 99 31 (28–34) n = 99 114 (71–149) n = 102 4.7 (4.2–5.1) n = 106 2.3 (2.0–2.7) n = 106 77 (72–89) n = 104 29 (26–34) n = 104 40 (37–46) n = 107
13 0.2 (0.1–1.1) n = 42 17.1 (15.3–18.8) n = 62 133 (114–270) n = 58 129 (49–143) n = 62 133 (118–153) n = 55 5.6 (5.3–5.8 n = 50 2.4 (2.2–2.6) n = 50 126 (99–149) n = 50 20 (17–23) n = 50 53 (46–62) n = 49
14 1.8 (1.5–2.4) n = 54 14.9 (13.8–16.2) n = 54 447 (365–528) n = 54 33 (31–37) n = 58 605 (495–892) n = 54 4.3 (3.3–5.2) n = 51 4.8 (3.3–5.8) n = 51 239 (194–267) n = 49 19 (18–23) n = 53 49 (38–71) n = 50

Brain-MD and CSF-MD parameters in median values, with 1st–3rd quartile in parenthesis. Sample size is the amount of MD samples acquired of the specific metabolite for each patient. The patients with pericontusional microdialysis catheters are in white rows, while the rows of patients with ipsilateral microdialysis catheters are gray. The amount of samples represents total monitored time (h).